宫颈癌卵巢移位后卵巢保护调强放疗的剂量学分析
对暴露最少卵巢的平均剂量>8 Gy或最大剂量>16 Gy者卵巢早衰风险更高,移位后1周内开始放疗未增加急性手术并发症。
要点
- 对暴露最少卵巢平均剂量>8 Gy或最大剂量>16 Gy者卵巢早衰风险升高。
- 卵巢早衰组对暴露最少卵巢的中位平均剂量为12.0 Gy,最大剂量为19.3 Gy。
- 移位后1周内开始放疗未观察到急性手术并发症增加。
核心结论
- 卵巢移位后放疗,对暴露最少卵巢平均剂量>8 Gy或最大剂量>16 Gy与卵巢早衰风险升高相关。
- 移位后1周内开始放疗未增加可识别的急性手术并发症。
研究设计与样本
- 中位诊断年龄32岁,中位随访52.2个月。
主要发现
- 卵巢早衰发生率为71%。
- 卵巢早衰组对暴露最少卵巢中位平均剂量12.0 Gy(IQR 2.8-19.2 Gy),中位最大剂量19.3 Gy(IQR 4.7-42.9 Gy)。
- 无卵巢早衰组对暴露最少卵巢中位平均剂量4.4 Gy(IQR 1.5-6.8 Gy),中位最大剂量5.9 Gy(IQR 2.4-11.4 Gy)。
- 对暴露最少卵巢平均剂量>8 Gy者全部发生卵巢早衰,<8 Gy者50%发生(P = .03);最大剂量>16 Gy者全部发生,<16 Gy者54.5%发生(P = .05)。
- 卵巢早衰组上方卵巢与计划靶区中位距离更小(2.55 cm vs 4.00 cm),卵巢复发1例但复发时已有广泛转移,手术至放疗中位时间40天(IQR 20-57天),3例1周内开始放疗均无急性手术并发症。
关键数值与推荐
- 对暴露最少卵巢平均剂量>8 Gy或最大剂量>16 Gy与卵巢早衰风险升高相关。
- 移位后1周内开始放疗未增加急性手术并发症。
临床怎么用
- 宫颈癌卵巢移位后放疗计划应尽量将对暴露最少卵巢的平均剂量控制在8 Gy以下、最大剂量控制在16 Gy以下。
- 卵巢移位后1周内开始放疗在急性手术并发症方面未见增加。
局限性
- 剂量约束与手术间隔的结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Ovarian transposition before the start of pelvic radiation therapy can potentially preserve ovarian function. However, it remains unclear what reasonable dose constraints are and how soon following transposition it is safe to start radiation therapy. METHODS AND MATERIALS: We performed a retrospective review of patients aged <50 years diagnosed with cervical cancer who underwent ovarian transposition before pelvic radiation therapy between 2010 and 2023. Endpoints examined included the incidence of premature ovarian insufficiency (POI), relapse in the ovary, and acute surgical complications. RESULTS: Seventeen patients met the inclusion criteria. Median age at diagnosis was 32 years. Median follow-up was 52.2 months. POI incidence was 71%. Among patients with POI, the median mean dose (Dmean) and maximum dose (Dmax) to the least-exposed ovary were 12.0 Gy (IQR, 2.8-19.2 Gy) and 19.3 Gy (IQR, 4.7-42.9 Gy), respectively. Among patients with no evidence of POI, the median Dmean and Dmax to the least-exposed ovary were 4.4 Gy (IQR, 1.5-6.8 Gy) and 5.9 Gy (IQR, 2.4-11.4 Gy), respectively. All patients with a Dmean to the least-exposed ovary >8 Gy developed POI compared with 50% of patients with a Dmean to the least-exposed ovary <8 Gy (P = .03). All patients with a Dmax to the least-exposed ovary >16 Gy developed POI compared with 54.5% of patients with a Dmax <16 Gy (P = .05). Patients with POI had a smaller median distance between the more superior ovary and the planning target volume (2.55 cm vs 4.00 cm). There was one relapse in the ovary; however, this patient was noted to have widely metastatic disease at the time of relapse. The median time from surgery to start of radiation therapy was 40 days (IQR, 20-57 days). Three patients started radiation therapy within 1 week; none had an acute surgical complication. CONCLUSIONS: Our data suggest that patients receiving a mean dose >8 Gy or a maximum dose >16 Gy to the least-exposed ovary following ovarian transposition are at higher risk of POI. Starting radiation therapy within 1 week of transposition was not associated with any identifiable increase in acute surgical complications.
引用
- Shogan JC, Sukumvanich P, Boisen M, et al. Ovary Sparing Intensity Modulated Radiation Therapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients With Cervical Cancer Treated With External Beam Radiation Therapy After Oophoropexy. Pract Radiat Oncol. 2026. PMID: 42409314. doi:10.1016/j.prro.2026.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。